Hosted on MSN26d
Venetoclax could improve outcomes of CAR T therapy for patients with resistant B-cell lymphomaswe expected that venetoclax would have a direct impact on CAR T cell populations through mitochondrial or endoplasmic reticulum (ER) protein interaction and localization," says presenting author ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback